EarningsSILVAPHL
SILVAPHL Earnings Update
Announcement summary
- What happened
- SILVAPHL published a corporate disclosure on 30 January 2024. Read the full announcement for details.
- Company
- Silva Pharmaceuticals Limited
- Announcement published
Original announcement
(Q2 Un-audited): EPS was Tk. (0.06) for October-December 2023 as against Tk. 0.14 for October-December 2022; EPS was Tk. (0.12) for July-December 2023 as against Tk. 0.33 for July-December 2022. NOCFPS was Tk. 0.17 for July-December 2023 as against Tk. 0.54 for July-December 2022. NAV per share was Tk. 16.88 as on December 31, 2023 and Tk. 17.10 as on June 30, 2023. Reasons for Deviation in EPS, NOCFPS and NAVPS: EPS has been decreased compared to the same period (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 65b87224edb49c4b75fb574c
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILVAPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.